189 related articles for article (PubMed ID: 11439417)
1. Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine.
Kohn Y; Weizman A; Apter A
Int J Eat Disord; 2001 Jul; 30(1):113-7. PubMed ID: 11439417
[TBL] [Abstract][Full Text] [Related]
2. Psychosis associated with fluoxetine in Prader-Willi syndrome.
Hergüner S; Motavalli Mukaddes N
J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):944-945. PubMed ID: 17667473
[No Abstract] [Full Text] [Related]
3. Failure of fluoxetine to modify the skin-picking behaviour of Prader-Willi syndrome.
Schepis C; Failla P; Siragusa M; Palazzo R; Romano C
Australas J Dermatol; 1998 Feb; 39(1):57-8. PubMed ID: 9529694
[No Abstract] [Full Text] [Related]
4. Psychiatric disorders in Prader-Willi syndrome: epidemiology and management.
Dykens E; Shah B
CNS Drugs; 2003; 17(3):167-78. PubMed ID: 12617696
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutical approach of obesity in Prader-Willi Syndrome].
Carvalho DF; Cercato C; Almeida MQ; Mancini MC; Halpern A
Arq Bras Endocrinol Metabol; 2007 Aug; 51(6):913-9. PubMed ID: 17934657
[TBL] [Abstract][Full Text] [Related]
6. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Maina G; Albert U; Salvi V; Bogetto F
J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
[TBL] [Abstract][Full Text] [Related]
7. Antisocial ideation and activities precipitated by the administration of SSRIs.
Glancy GD
Can J Psychiatry; 1993 Dec; 38(10):695. PubMed ID: 8313312
[No Abstract] [Full Text] [Related]
8. A 14-year-old male patient with diagnosis of Prader-Willi syndrome in Ethiopia: a case report.
Belay KE; Ayalew BL; Amogne MT; Alemneh TA; Geletew TK
J Med Case Rep; 2023 Dec; 17(1):530. PubMed ID: 38143282
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
Ricca V; Mannucci E; Mezzani B; Moretti S; Di Bernardo M; Bertelli M; Rotella CM; Faravelli C
Psychother Psychosom; 2001; 70(6):298-306. PubMed ID: 11598429
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
Warnock JK; Kestenbaum T
Arch Dermatol; 1992 Dec; 128(12):1623-5. PubMed ID: 1456757
[TBL] [Abstract][Full Text] [Related]
11. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study.
Greenberg DM; Bradford JM; Curry S; O'Rourke A
Bull Am Acad Psychiatry Law; 1996; 24(4):525-32. PubMed ID: 9001750
[TBL] [Abstract][Full Text] [Related]
12. A comparison of fluvoxamine and fluoxetine in the treatment of major depression.
Rapaport M; Coccaro E; Sheline Y; Perse T; Holland P; Fabre L; Bradford D
J Clin Psychopharmacol; 1996 Oct; 16(5):373-8. PubMed ID: 8889909
[TBL] [Abstract][Full Text] [Related]
13. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
[TBL] [Abstract][Full Text] [Related]
14. The use of fluoxetine in an adolescent with Prader-Willi syndrome.
Dech B; Budow L
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):298-302. PubMed ID: 2016235
[TBL] [Abstract][Full Text] [Related]
15. Cardiac side-effects of two selective serotonin reuptake inhibitors in middle-aged and elderly depressed patients.
Strik JJ; Honig A; Lousberg R; Cheriex EC; Van Praag HM
Int Clin Psychopharmacol; 1998 Nov; 13(6):263-7. PubMed ID: 9861576
[TBL] [Abstract][Full Text] [Related]
16. Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy.
Brzozowska A; Werner B
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):591-2. PubMed ID: 19877986
[No Abstract] [Full Text] [Related]
17. Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus.
Fujiwara-Sawada M; Imanishi T; Yoshida A; Baba J
J Pharm Pharmacol; 2003 Feb; 55(2):271-4. PubMed ID: 12631420
[TBL] [Abstract][Full Text] [Related]
18. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Moore ML; Eichner SF; Jones JR
Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
[TBL] [Abstract][Full Text] [Related]
19. Resolution of Selective Serotonin Reuptake Inhibitor-Associated Sexual Dysfunction After Switching From Fluvoxamine to Fluoxetine.
Moses TEH; Javanbakht A
J Clin Psychopharmacol; 2023 Jan-Feb 01; 43(1):71-73. PubMed ID: 36445984
[No Abstract] [Full Text] [Related]
20. Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder.
Landeros-Weisenberger A; Bloch MH; Kelmendi B; Wegner R; Nudel J; Dombrowski P; Pittenger C; Krystal JH; Goodman WK; Leckman JF; Coric V
J Affect Disord; 2010 Feb; 121(1-2):175-9. PubMed ID: 19577308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
